BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 177 found
  Current Search:  yasmin: 177     

HTML
100%
Teva to buy Barr Pharma for more than US$7 billion in generic drug combination
TRENTON, N.J.

- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly US$7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

KBS Radio:  Jul 19 2008 5:23PM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for more than US$7 billion in generic drug combination
TRENTON, N.J.

- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly US$7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

Q97.5 EZ Rock:  Jul 19 2008 4:47PM
Matching: yasmin
Find similar documents
HTML
100%
Generic drugmaker Teva to buy rival Barr
TRENTON Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues consolidation...

CourierPostOnline.com:  Jul 19 2008 12:45PM
Matching: yasmin
Find similar documents
HTML
100%
Generic giant Teva to buy N.J. rival Barr for $7.5B
TRENTON Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues consolidation...

Asbury Park Press:  Jul 19 2008 11:49AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to purchase Barr Pharma for more than $7B
New York - Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S.

and Eastern European markets.

Teva Pharmaceutical...

TheDay.com:  Jul 19 2008 11:32AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to Buy Barr Pharma for More Than $7 Billion
NEW YORK -- Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S.

and Eastern European markets.

Teva Pharmaceutical...

MoneyNews.com:  Jul 19 2008 9:29AM
Matching: yasmin
Find similar documents
HTML
100%
Teva Pharmaceutical plans to buy rival drug maker Barr Pharmaceuticals for nearly $7.5 billion
TRENTON, N.J.

Teva Pharmaceutical said Friday that it would buy rival generic drug maker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drug maker.

The deal...

Los Angeles Times:  Jul 19 2008 8:11AM
Matching: yasmin
Find similar documents
HTML
100%
Teva agrees to buy Barr for $7.5B
Teva Pharmaceutical said yesterday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues consolidation of...

Times of Trenton:  Jul 19 2008 5:17AM
Matching: yasmin
Find similar documents
HTML
100%
Teva agrees to buy Barr for $7.5B
Teva Pharmaceutical said yesterday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues consolidation of...

Star Ledger:  Jul 19 2008 4:52AM
Matching: yasmin
Find similar documents
HTML
100%
Teva says it will buy Barr, a rival in generic drugs
TRENTON, N.J.

- In the latest drug consolidation, Teva Pharmaceutical said yesterday that it would buy rival generic drug-maker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest...

Winston-Salem Journal:  Jul 19 2008 4:47AM
Matching: yasmin
Find similar documents
HTML
100%
Teva Pharma to buy rival Barr for more than $7B
More Daily Report articles Tools: Print Text Size Email Reprints Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move that will boost Teva's dominance as the world's...
Atlanta Daily Report:  Jul 19 2008 4:46AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for more than US$7 billion in generic drug combination
TRENTON, N.J.

- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly US$7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

Sun FM:  Jul 19 2008 3:29AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for more than US$7 billion in generic drug combination
TRENTON, N.J.

- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly US$7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

CJFW:  Jul 19 2008 2:26AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for more than $7 billion
Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues consolidation of the...

Belleville News Democrat:  Jul 19 2008 2:12AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for more than US$7 billion in generic drug combination
TRENTON, N.J.

- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly US$7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

Golden EzRock:  Jul 19 2008 1:32AM
Matching: yasmin
Find similar documents
HTML
100%
Teva To Buy Barr Pharma For More Than $7 billion
TRENTON, N.J.

-- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

Fox 2 KASA:  Jul 19 2008 12:26AM
Matching: yasmin
Find similar documents
HTML
100%
Teva To Buy Barr Pharma For More Than $7 billion
TRENTON, N.J.

-- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

MyFox Houston:  Jul 19 2008 12:11AM
Matching: yasmin
Find similar documents
HTML
100%
Teva to pay more than $7 billion for Barr Pharma, to boost global generic drug dominance
TRENTON, N.J.

(AP) _ Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

AP via Newsday:  Jul 18 2008 11:27PM
Matching: yasmin
Find similar documents
HTML
100%
Teva to pay $A7.2bn for Barr Pharma
Aust markets: Aussie stocks down Aust dollar report: $A dollar closes weaker as euro falls Aust credit close: Bonds close weaker ahead of CPI data World reports World commodities: Oil prices fall sharply World markets: US stocks surge for...
Trading Room:  Jul 18 2008 11:20PM
Matching: yasmin
Find similar documents
HTML
100%
Teva to pay $A7.2bn for Barr Pharma
Israel's Teva Pharmaceutical will buy rival US generic drug company Barr Pharmaceuticals for more than $US7 billion ($A7.2 billion) in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

Israel-based Teva...

WA Today.com.au:  Jul 18 2008 11:02PM
Matching: yasmin
Find similar documents
HTML
100%
Teva To Buy Barr Pharma For More Than $7 billion
TRENTON, N.J.

-- Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The deal continues...

Fox 4 WDAF TV:  Jul 18 2008 11:02PM
Matching: yasmin
Find similar documents
HTML
100%
Teva to pay $A7.2bn for Barr Pharma
Israel's Teva Pharmaceutical will buy rival US generic drug company Barr Pharmaceuticals for more than $US7 billion ($A7.2 billion) in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

Israel-based Teva...

Sydney Morning Herald:  Jul 18 2008 10:58PM
Matching: yasmin
Find similar documents
HTML
100%
UPDATED: Israeli firm to buy Barr Pharma for more than $7 billion
Israeli drugmaker Teva Pharmaceutical will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S.

and Eastern European markets.

Barr Laboratories, a subsidiary of New Jersey...

Lynchburg News and Advance:  Jul 18 2008 10:57PM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for $7.2B
The deal will give Teva a larger presence in Central and Eastern Europe, as well as access to Barr products that include birth control pill Yasmin and a generic version of Adderall.

(AP) - Israeli drugmaker Teva Pharmaceutical said...

Crains NY Business:  Jul 18 2008 6:18PM
Matching: yasmin
Find similar documents
HTML
100%
Teva to buy Barr Pharma for $7.2B
The deal will give Teva a larger presence in Central and Eastern Europe, as well as access to Barr products that include birth control pill Yasmin and a generic version of Adderall.

(AP) - Israeli drugmaker Teva Pharmaceutical said...

Crains NY Business:  Jul 18 2008 1:40PM
Matching: yasmin
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.